NCT07573709Terminated
Functional and Affective Effects of a Brief tDCS Intervention in Fibromyalgia and Chronic Fatigue Syndrome
Source: ClinicalTrials.gov · Last updated 7 May 2026
Reason given: Not stopped. It is completed.
Brief summary (registry, in English)
Functional and Affective Effects of a brief tDCS Intervention in Fibromyalgia and Chronic Fatigue Syndrome Fibromyalgia (FM) and chronic fatigue syndrome (CFS) are characterized by persistent, multidimensional symptoms arising from complex brain-body interactions that impair functioning and quality of life. Noninvasive neuromodulation techniques such as transcranial direct current stimulation (tDCS) have been proposed as adjunctive approaches to support short-term functional changes within distributed neural systems, although evidence remains limited and heterogeneous. The objective is to examine immediate pre-post changes in multidimensional clinical outcomes following a standardized tDCS protocol in patients with FM and CFS, and to explore potential diagnosis-related response patterns.
- Status (registry)
- Terminated
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 21 Apr 2026
- Start date
- 1 Jan 2025
- Primary completion date
- 1 May 2025
- Lead sponsor
- Hospital Donostia
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT07573709
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Having both conditions at the same time
Who the study is looking for
- Diagnosis of Fibromyalgia
- Diagnosis of chronic fatigue syndrome
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitario de Donostia | San Sebastián | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.